Literature DB >> 16704575

Adaptive servo-ventilation and deadspace: effects on central sleep apnoea.

I Szollosi1, D M O'Driscoll, M J Dayer, A J Coats, M J Morrell, A K Simonds.   

Abstract

Central Sleep Apnoea (CSA) occurs commonly in heart failure. Adaptive servo-ventilation (ASV) and deadspace (DS) have been shown in research settings to reverse CSA. The likely mechanism for this is the increase of PaCO(2) above the apnoeic threshold. However the role of increasing FiCO(2) on arousability remains unclear. To compare the effects of ASV and DS on sleep and breathing, in particular effects on Arousal Index (ArI), ten male patients with heart failure and CSA were studied during three nights with polysomnography plus measurements of PetCO(2). The order of the interventions control (C), ASV and DS was randomized. ASV and DS caused similar reductions in apnoea-hypopnoea index [(C) 30.0 +/- 6.6, (ASV) 14.0 +/- 3.8, (DS) 15.9 +/- 4.7 e h(-1); both P < 0.05]. However, DS was associated with decreased total sleep time compared with C (P < 0.02) and increased spontaneous ArI compared to C and ASV (both P < 0.01). Only DS was associated with increased DeltaPetCO(2) from resting wakefulness to eupnic sleep [(C) 2.1 +/- 0.9, (ASV) 1.3 +/- 1.0, (DS) 5.6 +/- 0.5 mmHg; P = 0.01]. ASV and DS both stabilized ventilation however DS application also increased sleep fragmentation with negative impacts on sleep architecture. We speculate that this effect is likely to be mediated by increased PetCO(2) and respiratory effort associated with DS application.

Entities:  

Mesh:

Year:  2006        PMID: 16704575     DOI: 10.1111/j.1365-2869.2006.00515.x

Source DB:  PubMed          Journal:  J Sleep Res        ISSN: 0962-1105            Impact factor:   3.981


  21 in total

1.  Relation of natriuretic peptide concentrations to central sleep apnea in patients with heart failure.

Authors:  Andrew D Calvin; Virend K Somers; Christelle van der Walt; Christopher G Scott; Lyle J Olson
Journal:  Chest       Date:  2011-06-02       Impact factor: 9.410

2.  Bench test evaluation of adaptive servoventilation devices for sleep apnea treatment.

Authors:  Kaixian Zhu; Haissam Kharboutly; Jianting Ma; Mourad Bouzit; Pierre Escourrou
Journal:  J Clin Sleep Med       Date:  2013-09-15       Impact factor: 4.062

3.  Heart failure, central sleep apnea, CPAP, and arousals: another piece of the puzzle.

Authors:  Kenneth R Casey
Journal:  Sleep       Date:  2009-01       Impact factor: 5.849

4.  Treatment of positive airway pressure treatment-associated respiratory instability with enhanced expiratory rebreathing space (EERS).

Authors:  Geoffrey Gilmartin; Brennden McGeehan; Kevin Vigneault; Robert W Daly; Megan Manento; J Woodrow Weiss; Robert Joseph Thomas
Journal:  J Clin Sleep Med       Date:  2010-12-15       Impact factor: 4.062

Review 5.  The treatment of central sleep apnea syndromes in adults: practice parameters with an evidence-based literature review and meta-analyses.

Authors:  R Nisha Aurora; Susmita Chowdhuri; Kannan Ramar; Sabin R Bista; Kenneth R Casey; Carin I Lamm; David A Kristo; Jorge M Mallea; James A Rowley; Rochelle S Zak; Sharon L Tracy
Journal:  Sleep       Date:  2012-01-01       Impact factor: 5.849

6.  Left atrial size, chemosensitivity, and central sleep apnea in heart failure.

Authors:  Andrew D Calvin; Virend K Somers; Bruce D Johnson; Christopher G Scott; Lyle J Olson
Journal:  Chest       Date:  2014-07       Impact factor: 9.410

7.  Adaptive servoventilation in patients with central or complex sleep apnea related to chronic opioid use and congestive heart failure.

Authors:  Kannan Ramar; Priya Ramar; Timothy I Morgenthaler
Journal:  J Clin Sleep Med       Date:  2012-10-15       Impact factor: 4.062

8.  Treatment of central sleep apnea in U.S. veterans.

Authors:  Susmita Chowdhuri; Ahmed Ghabsha; Prabhat Sinha; Medina Kadri; Simranjit Narula; M Safwan Badr
Journal:  J Clin Sleep Med       Date:  2012-10-15       Impact factor: 4.062

9.  Sleep dysfunction in heart failure.

Authors:  Shahrokh Javaheri
Journal:  Curr Treat Options Neurol       Date:  2008-09       Impact factor: 3.598

10.  Adaptive pressure support servoventilation: a novel treatment for sleep apnea associated with use of opioids.

Authors:  Shahrokh Javaheri; Athar Malik; Jason Smith; Eugene Chung
Journal:  J Clin Sleep Med       Date:  2008-08-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.